Mental Health and Addictions



Acknowledgements

We acknowledge our office is located on Treaty 1 Territory and that Manitoba is located on the Treaty Territories and ancestral lands of the Anishinaabeg, Anishininewuk, Dakota Oyate, Denesuline and Nehethowuk Nations.

We acknowledge Manitoba is located on the Homeland of the Red River Métis.

We acknowledge northern Manitoba includes lands that were and are the ancestral lands of the Inuit.

We respect the spirit and intent of Treaties and Treaty Making and remain committed to working in partnership with First Nations, Inuit and Métis people in the spirit of truth, reconciliation and collaboration.


Introduction

This interactive report, provides the currently available information on substance use and related harms in Manitoba. Five key indicators are summarized in this report: Substance-related deaths (SRDs), Substance-related hospital admissions, Substance-related emergency department (ED) visits, Suspected overdose events attended by Winnipeg Fire & Paramedics Service (WFPS) and Take-Home Naloxone Kit (THNK) distribution. This dashboard will be updated mid-month at the beginning of each quarter (Jan, Apr, Jul, Oct), and will include data up to the end of the preceding quarter (where available) from the following four data sources:

Office of the Chief Medical Examiner (OCME).

  • The OCME is the data source for substance-related deaths. In an effort to provide timely information these deaths are assessed based on toxicological findings prior to the completion of a finalized autopsy.

Hospital Data - Two Sources.

  1. Discharge Abstracts Database (DAD), is the source for all substance related in-patient admissions. These are identified as patients who have had at least one substance-related discharge diagnosis. The availability of this data source can be 3-6 months behind as it undergoes additional validation before being released.
  2. Emergency Department Information System (EDIS), is the source for all substance-related emergency department (ED) visits. These are identified as either having a substance-related discharge diagnosis, or by a keyword search in the ED visit reason field. This data source is updated on an ongoing basis. This data set however, does not fully cover all EDs within Manitoba. Only ED’s that are connected to EDIS are included, which means some smaller rural ED’s are left out from this source.

Emergency Medical Services (EMS) - Winnipeg Fire and Paramedic Service (WFPS) Data

Take-Home Naloxone (THN) Kit distribution data

  • Data is obtained in the Public Health Information Management System (PHIMS), which tracks the distribution of take-home naloxone kits to their distribution sites throughout the Province. This data source is updated on an ongoing basis.


Provincial Overview


*Substance-related death data is subject to change as more information becomes available. This may mean that the most recent data may be underrepresented.

Quarters are defined by calendar quarters. I.e. Q1: Jan - Mar, Q2: Apr - Jun, Q3: Jul - Sep, Q4: Oct - Dec.



Deaths


Trend

*Confirmed fatality counts (bars) are based on the left axis, while crude rates (line graph) are based on the right axis.


Definition: Substance-related deaths are deaths due entirely, or at least in part, to the toxic effects of one or more substances, including alcohols. A death is considered opioid related if at least one of the substances contributing to causing death is an opioid. It is important to note that deaths due to the effects of chronic substance abuse, or deaths due to other causes where substance intoxication may have circumstantially contributed (i.e., drunk driving, hypothermia, drownings), are excluded from this case definition.


Substance-related deaths Key observations:
- Stimulants are the leading substance causing death in Manitoba. Methamphetamine and Cocaine contributed to over 80% of the total deaths from June to August 2024.
- Manitoba experiences a higher proportion of substance-related deaths among females when compared to the Canadian average.
- The vast majority of substance-related deaths have multiple substances present at the time of death.
- For further information on Manitoba in comparison to Canada, please see: Key findings: Opioid- and Stimulant-related Harms in Canada — Canada.ca


The trend of co-involvement of multiple substances in the deaths reported in Q1 and Q2 of 2024 also continued in Q3. Similarly, stimulants, largely methamphetamine and cocaine, contributed the largest proportion of the 128 deaths reported for Q3 (103, 80.5%), while benzodiazepines contributed the least (54, 42.2%). A broader overview of drug-related deaths in the past three years (January 2022-October 2024) shows that, while the annual total number of deaths has been increasing, the increase appears to be mostly driven by stimulants. Based on currently available data for 2024, a 46% increase in drug-related deaths is projected by December 2024 compared to January 2022. However, while the number of deaths involving opioids alone or in combination with substances other than stimulants has remained largely stable over this period, the number of deaths that involved stimulants is on course to cause a 51% increase in the deaths over the same period.



Demographics

  • For January 2022 to September 2024
  • Displayed as crude rate per 100,000 Manitoba residents.


By RHA

  • Under Construction



Hospitalizations / ED Presentations


Inpatient Admissions

  • Please see glossary for definition of categories.


Emergency Department Presentations

  • Please see glossary for definition of categories.
  • Categories are defined by the ED discharge diagnosis provided in EDIS.
  • Note that a discharge diagnosis is not always provided, and thus this may be an under-representation of the actual number within each category. The total however, includes all identified substance-related
    presentations, whether a diagnosis code was provided or not.


  • ED overdose presentations are identified in EDIS using a keyword search in the ED chief complaint field.



WFPS Attended Events


Trend

  • Categories are defined by WFPS, as the main cause for the need for WFPS personnel to attend an event.


  • Suspected opioid overdose events are WFPS-attended events where Naloxone/Narcan was administered.


Demographics

  • For January 2025 to March 2025 inclusive.
  • Displayed as crude rate per 100,000 Winnipeg residents.


By Neighbourhood Cluster

  • For January 2025 to March 2025 inclusive.
  • Displayed as crude rate per 100,000 residents.
  • Geo-coded as the neighbourhood cluster that the event was responded to at. Not necessarily the neighbourhood cluster of residence for the person being responded to.



Take-Home Naloxone Distribution

Note that holding points are not necessarily the final point of distribution of the take-home naloxone kits. Also, a person from one RHA may obtain a kit from another RHA, so this is not a fully accurate picture of where each take-home naloxone kit is eventually kept and/or used.


Glossary

Abbreviations

DAD: Discharge Abstracts Database

ED: Emergency Department

EDIS: Emergency Department Information System

EMS: Emergency Medical Services

OCME: Office of the Chief Medical Examiner

PHIMS: Public Health Information Management System

Q1-Q4: Quarters one through four, as defined by calendar quarters. I.e. Q1: Jan - Mar, Q2: Apr - Jun, Q3: Jul - Sep, Q4: Oct - Dec.

THN: Take-Home Naloxone

WFPS: Winnipeg Fire and Paramedic Service


Diagnosis Codes

Hospital and ED related substance diagnoses are categorized using the International Classification of Diseases 10th revision (ICD-10) diagnoses codes. These are:

  • Alcohol:
    • F10.1 - F10.9: Alcohol-related disorders
    • T51.0-T51.9: Toxic effect of alcohol
    • X45.0-X45.9: Accidental poisoning by and exposure to alcohol
    • X65.0-X65.0: Intentional self-poisoning by and exposure to alcohol
    • Y15.0-Y15.9: Poisoning by and exposure to alcohol, undetermined intent
  • Cocaine:
    • F14.0-F14.9: Cocaine-related disorders
    • T40.5: Poisoning by cocaine
  • Opioids:
    • F11.1-F11.9: Opioid abuse/dependence
    • T40.0: Poisoning by opium
    • T40.1: Poisoning by heroin
    • T40.2: Poisoning by other opioids
    • T40.3: Poisoning by methadone
    • T40.3: Poisoning by other narcotics
    • T40.4: Poisoning by synthetic narcotics
    • T40.6: Poisoning by unspecified narcotics
  • Other Depressants:
    • F13.10-F13.19: Sedative-hypnotic-, or anxiolytic-related disorders
    • T42.3: Poisoning by barbiturates
    • T42.4: Poisoning by benzodiazepines
    • T42.6: Poisoning by other antiepileptic and sedative-hypnotic drugs
    • T42.7: Poisoning by antiepileptic and sedative-hypnotic drugs, unspecified.
  • Other Stimulants:
    • F15.1-F15.9: Other stimulant-related disorders
    • T43.6: Poisoning by psychostimulants